Cardinal Health Inc (CAH) stock
CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3042% above fair value
$278.32−0.93 (-0.33%)
Close on Nov 18, 2026Market cap $64.73BP/E 38.5Yield 0.73%
Cardinal Health revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Cardinal Health's revenue for the twelve months ending Jun 30, 2026 was $254.25B, up 14.2% year over year. For fiscal 2026 it was $254.25B, up 14.2% from the year before. Over ten years it grew 7.7% a year on average. The highest annual figure on record is $254.25B in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $254.25B | +14.2% |
| FY2025 | Jun 30, 2025 | $222.58B | -1.9% |
| FY2024 | Jun 30, 2024 | $226.83B | +10.7% |
| FY2023 | Jun 30, 2023 | $204.98B | +13.0% |
| FY2022 | Jun 30, 2022 | $181.33B | +11.6% |
| FY2021 | Jun 30, 2021 | $162.47B | +6.2% |
| FY2020 | Jun 30, 2020 | $152.92B | +5.1% |
| FY2019 | Jun 30, 2019 | $145.53B | +6.4% |
| FY2018 | Jun 30, 2018 | $136.81B | +5.3% |
| FY2017 | Jun 30, 2017 | $129.98B | +6.9% |
| FY2016 | Jun 30, 2016 | $121.55B | +18.5% |
| FY2015 | Jun 30, 2015 | $102.53B | +12.6% |
| FY2014 | Jun 30, 2014 | $91.08B | -9.9% |
| FY2013 | Jun 30, 2013 | $101.09B | -6.0% |
| FY2012 | Jun 30, 2012 | $107.55B | +4.8% |
| FY2011 | Jun 30, 2011 | $102.64B | +4.2% |
| FY2010 | Jun 30, 2010 | $98.50B | +2.6% |
| FY2009 | Jun 30, 2009 | $95.99B | +9.8% |
| FY2008 | Jun 30, 2008 | $87.41B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $63.67B | +5.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $60.94B | +11.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $65.63B | +18.8% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $64.01B | +22.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $60.16B | +0.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $54.88B | +0.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $55.26B | -3.8% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $52.28B | -4.3% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $59.87B | +12.1% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $54.87B | +8.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $57.44B | +11.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $54.65B | +10.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $53.42B | +13.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $50.50B | +12.6% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $51.47B | +13.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $49.59B | +12.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $47.07B | +10.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $44.84B | +14.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $45.46B | +9.4% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $43.97B | +12.6% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $42.59B | +16.1% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $39.28B | +0.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $41.54B | +4.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $39.07B | +4.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $36.69B | -1.8% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $39.16B | +11.2% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $39.74B | +5.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $37.34B | +6.0% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $37.35B | +5.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $35.23B | +4.7% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $37.74B | +7.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $35.21B | +7.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $35.35B | +7.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $33.63B | +5.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $35.19B | +6.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $32.64B | +1.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $32.97B | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $31.82B | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $33.15B | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $32.04B | – |
See a number that looks wrong?